Moroccan healthcare company SoPharma has announced the acquisition of a majority stake in Compagnie des équipements et solutions médicaux d’Afrique (CESMA), a leading distributor of specialized medical devices in Morocco. Founded in 1987 by Azeddine El Khenati, CESMA has nearly four decades of experience in the industry. This strategic partnership marks SoPharma's entry into the medical devices sector, expanding its presence in the healthcare market.
The acquisition is part of SoPharma's plan to build an integrated healthcare group. According to Ismail Cheikh-Lahlou, co-founder and CEO of SoPharma, this partnership is a natural extension of their current activities, offering strong synergies and an expanded range of services for healthcare professionals and institutions. SoPharma aims to leverage CESMA's expertise and experience to drive growth and strengthen its position in the market.
CESMA's founder, Azeddine El Khenati, expressed his enthusiasm for the partnership, highlighting the significance of this development for the company as it approaches its 40th anniversary. El Khenati emphasized that the partnership will enable CESMA to consolidate its position in a rapidly growing sector, accelerate its development, and preserve the values that have contributed to its success.
The partnership is expected to support CESMA's growth in the context of Morocco's expanding healthcare infrastructure and medical coverage. SoPharma's entry into the medical devices sector is seen as a strategic move to capitalize on emerging opportunities in the market. The company aims to work closely with CESMA's experienced team to drive growth and innovation.
In terms of advisory support, CESMA was assisted by Ascent Capital Partners as financial advisors and ASAFO & Co. as legal advisors. SoPharma received advisory support from FinTrust Capital, LAWAL, and Ecovis Morocco in financial, legal, and audit matters, respectively. The partnerships reflect the companies' commitment to ensuring a smooth transition and successful collaboration.
SoPharma's acquisition of a majority stake in CESMA is seen as a significant development in Morocco's healthcare sector. The partnership is expected to have a positive impact on the market, driving growth and innovation in the medical devices sector. With SoPharma's support, CESMA is poised to strengthen its position and expand its offerings to healthcare professionals and institutions.
The acquisition marks a new chapter in SoPharma's growth trajectory, as the company continues to build its presence in the healthcare market. With a focus on delivering high-quality services and products, SoPharma is well-positioned to capitalize on emerging opportunities in the medical devices sector. The partnership with CESMA is a strategic move to drive growth and innovation in the industry.
Key points
- SoPharma acquires majority stake in CESMA to expand presence in medical devices sector
- Partnership aims to drive growth and innovation in Morocco's healthcare market
- Acquisition marks SoPharma's entry into medical devices sector, expanding its integrated healthcare group
